IP Library › Assignment 055778/0867
Patent Assignment
Reel/Frame 055778/0867

Assignment of Assignor's Interest

Recorded: 2021-03-31 Pages: 26
Assignors
KELLY, PATRICK F.
Executed: 2021-01-13
COLLIS, ALAN
Executed: 2021-03-04
DAVIS, JEFF
Executed: 2021-01-26
WALKER, DUNCAN
Executed: 2021-02-14
LU, WEI
Executed: 2021-01-13
ASHWELL, SUSAN
Executed: 2020-12-01
THOMSON, BLYTHE
Executed: 2020-11-30
Assignee
FORMA THERAPEUTICS, INC.
500 ARSENAL STREET, SUITE 100, WATERTOWN, MASSACHUSETTS, 02472
Covered Properties (21)
INHIBITING MUTANT ISOCITRATE DEHYDROGENASE 1 (mIDH-1)
Application: 16/893,147 →
Publication: US 2020/0297717
Administration of a Mutated Isocitrate Dehydrogenase-1 (Idh-1) Inhibitor for the Treatment of Acute Myeloid Leukemia (Aml) or Myelodysplastic Syndrome (Mds)
Application: 62/672,461 →
ADMINISTRATION OF A MUTATED ISOCITRATE DEHYDROGENASE 1 (mIDH-1) INHIBITOR FOR THE TREATMENT OF ACUTE MYELOID LEUKEMIA (AML) OR MYELODYSPLASTIC SYNDROME (MDS)
Application: 62/672,462 →
SELECTIVE INHIBITION OF MUTANT ISOCITRATE DEHYDROGENASE 1 (mIDH-1)
Application: 62/680,560 →
Inhibiting Mutant Isocitrate Dehydrogenase 1 (Midh-1) in the Central Nervous System
Application: 62/680,562 →
DURABLE ADMINISTRATION OF AN INHIBITOR OF MUTATED ISOCITRATE DEHYDROGENASE-1 (mIDH-1)
Application: 62/680,566 →
Treating Acute Myeloid Leukemia (Aml) or Myelodysplastic Syndrome (Mds) Harboring a Isocitrate Dehydrogenase-1 (Idh-1) Mutation
Application: 62/680,571 →
TREATING SOLID TUMORS HARBORING MUTANT ISOCITRATE DEHYDROGENASE 1 (mIDH-1)
Application: 62/692,598 →
TREATING SOLID TUMORS HARBORING MUTANT ISOCITRATE DEHYDROGENASE 1 (mIDH-1)
Application: 62/692,601 →
TREATING SOLID TUMORS HARBORING MUTANT ISOCITRATE DEHYDROGENASE 1 (mIDH-1)
Application: 62/692,604 →
TREATING SOLID TUMORS HARBORING MUTANT ISOCITRATE DEHYDROGENASE 1 (mIDH-1)
Application: 62/692,605 →
Treating Acute Myeloid Leukemia (Aml) or Myelodysplastic Syndrome (Mds) Harboring a Isocitrate Dehydrogenase-1 (Idh-1) Mutation
Application: 62/701,487 →
Treating Acute Myeloid Leukemia (Aml) or Myelodysplastic Syndrome (Mds) Harboring a Isocitrate Dehydrogenase-1 (Idh-1) Mutation
Application: 62/712,160 →
Treating Acute Myeloid Leukemia (Aml) or Myelodysplastic Syndrome (Mds) Harboring a Isocitrate Dehydrogenase-1 (Idh-1) Mutation
Application: 62/773,562 →
TREATING SOLID TUMORS HARBORING MUTANT ISOCITRATE DEHYDROGENASE 1 (mIDH-1)
Application: 62/798,677 →
TREATING SOLID TUMORS HARBORING MUTANT ISOCITRATE DEHYDROGENASE 1 (mIDH-1)
Application: 62/798,681 →
TREATING SOLID TUMORS HARBORING MUTANT ISOCITRATE DEHYDROGENASE 1 (mIDH-1)
Application: 62/798,684 →
TREATING SOLID TUMORS HARBORING MUTANT ISOCITRATE DEHYDROGENASE 1 (mIDH-1)
Application: 62/798,687 →
Treating Acute Myeloid Leukemia (Aml) or Myelodysplastic Syndrome (Mds) Harboring a Isocitrate Dehydrogenase-1 (Idh-1) Mutation
Application: 62/798,690 →
Treating Acute Myeloid Leukemia (Aml) or Myelodysplastic Syndrome (Mds) Harboring a Isocitrate Dehydrogenase-1 (Idh-1) Mutation
Application: 62/812,367 →
Inhibiting Mutant Isocitrate Dehydrogenase 1
Application: 63/023,813 →
Related Assignments (23)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Jun 28, 2018
From: ASHWELL, SUSAN
To: FORMA THERAPEUTICS, INC.
Reel/Frame 046228/0001 →
Assignment of Assignor's Interest Jun 28, 2018
From: KELLY, PATRICK F.; COLLIS, ALAN; DAVIS, JEFF; WALKER, DUNCAN
To: FORMA THERAPEUTICS, INC.
Reel/Frame 046226/0661 →
Assignment of Assignor's Interest Jun 28, 2018
From: KELLY, PATRICK F.; COLLIS, ALAN; DAVIS, JEFF; WALKER, DUNCAN
To: FORMA THERAPEUTICS, INC.
Reel/Frame 046226/0836 →
Assignment of Assignor's Interest Jun 28, 2018
From: ASHWELL, SUSAN
To: FORMA THERAPEUTICS, INC.
Reel/Frame 046227/0908 →
Assignment of Assignor's Interest Mar 6, 2019
From: DAVIS, JEFF; THOMSON, BLYTHE
To: FORMA THERAPEUTICS, INC.
Reel/Frame 048513/0877 →
Assignment of Assignor's Interest Mar 6, 2019
From: DAVIS, JEFF; THOMSON, BLYTHE
To: FORMA THERAPEUTICS, INC.
Reel/Frame 048513/0895 →
Assignment of Assignor's Interest Mar 6, 2019
From: DAVIS, JEFF; THOMSON, BLYTHE
To: FORMA THERAPEUTICS, INC.
Reel/Frame 048513/0914 →
Assignment of Assignor's Interest Mar 6, 2019
From: DAVIS, JEFF; THOMSON, BLYTHE
To: FORMA THERAPEUTICS, INC.
Reel/Frame 048513/0815 →
Assignment of Assignor's Interest May 3, 2019
From: KELLY, PATRICK F.; COLLIS, ALAN; DAVIS, JEFF; WALKER, DUNCAN
To: FORMA THERAPEUTICS, INC.
Reel/Frame 049072/0298 →
Assignment of Assignor's Interest May 3, 2019
From: KELLY, PATRICK F.; COLLIS, ALAN; DAVIS, JEFF; WALKER, DUNCAN
To: FORMA THERAPEUTICS, INC.
Reel/Frame 049072/0456 →
Assignment of Assignor's Interest May 3, 2019
From: KELLY, PATRICK F.; COLLIS, ALAN; DAVIS, JEFF; WALKER, DUNCAN
To: FORMA THERAPEUTICS, INC.
Reel/Frame 049072/0466 →
Assignment of Assignor's Interest May 3, 2019
From: DAVIS, JEFF; THOMSON, BLYTHE
To: FORMA THERAPEUTICS, INC.
Reel/Frame 049072/0482 →
Assignment of Assignor's Interest May 3, 2019
From: DAVIS, JEFF; THOMSON, BLYTHE
To: FORMA THERAPEUTICS, INC.
Reel/Frame 049072/0490 →
Assignment of Assignor's Interest May 3, 2019
From: DAVIS, JEFF; THOMSON, BLYTHE
To: FORMA THERAPEUTICS, INC.
Reel/Frame 049072/0498 →
Assignment of Assignor's Interest May 3, 2019
From: DAVIS, JEFF; THOMSON, BLYTHE
To: FORMA THERAPEUTICS, INC.
Reel/Frame 049072/0506 →
Assignment of Assignor's Interest May 3, 2019
From: KELLY, PATRICK F.; COLLIS, ALAN; DAVIS, JEFF; WALKER, DUNCAN
To: FORMA THERAPEUTICS, INC.
Reel/Frame 049072/0328 →
Assignment of Assignor's Interest May 9, 2019
From: KELLY, PATRICK F.; COLLIS, ALAN; DAVIS, JEFF; WALKER, DUNCAN
To: FORMA THERAPEUTICS, INC.
Reel/Frame 049130/0400 →
Assignment of Assignor's Interest May 9, 2019
From: KELLY, PATRICK F.; COLLIS, ALAN; DAVIS, JEFF; WALKER, DUNCAN
To: FORMA THERAPEUTICS, INC.
Reel/Frame 049130/0444 →
Assignment of Assignor's Interest May 9, 2019
From: KELLY, PATRICK F.; COLLIS, ALAN; DAVIS, JEFF; WALKER, DUNCAN
To: FORMA THERAPEUTICS, INC.
Reel/Frame 049130/0369 →
Assignment of Assignor's Interest Sep 17, 2019
From: LUKE, GEORGE P.
To: FORMA THERAPEUTICS, INC.
Reel/Frame 050403/0713 →
Assignment of Assignor's Interest Sep 17, 2019
From: LUKE, GEORGE P.
To: FORMA THERAPEUTICS, INC.
Reel/Frame 050403/0756 →
Assignment of Assignor's Interest May 15, 2020
From: KELLY, PATRICK F.
To: FORMA THERAPEUTICS, INC.
Reel/Frame 052672/0056 →
Security Interest May 8, 2026
From: RIGEL PHARMACEUTICALS, INC.
To: MIDCAP FUNDING IV TRUST
Reel/Frame 075576/0880 →